NCT00884494View on ClinicalTrials.gov

Ghrelin and Insulin Resistance

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
ObesityInsulin ResistanceNormal Weight,Healthy Controls
Interventions
DRUG

Ghrelin infusion to assess effects on insulin sensitivity

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT00884494 - Ghrelin and Insulin Resistance | Biotech Hunter | Biotech Hunter